This is an alphabetical list of CRAS Academy Glossary Terms.
ACD
Anaemia of chronic disease
ACEI
Angiotensin-converting enzyme inhibitor
ADQI
Acute Dialysis Quality Initiative
ADHF
Acute decompensated heart failure
ARB
Angiotensin receptor-blocker
CERA
Continuous erythropoietin receptor activator
CHARM
Candesartan in Heart Failure-Assessment of Reduction in Mortality and Morbidity
CHF
Chronic heart failure
CHr
Reticulocyte haemoglobin content
CI
Confidence interval
CSN
Canadian Society of Nephrology
CRAS
Cardio-renal anaemia syndrome
CRS
Cardio-renal syndrome
EACPR
European Association for Cardiovascular Prevention and Rehabilitation
EBPG
European Best Practice Guidelines
EDTNA / ERCA
European Dialysis and Transplant Nurses Association / European Renal Care Association
eGFR
Estimated glomerular filtration rate
EPO
Erythropoietin
ERA-EDTA
European Renal Association – European Dialysis and Transplant Association
ERBP
European Renal Best Practice
ESAs
Erythropoiesis-stimulating agents
ESC
European Society of Cardiology
ESH
European Society of Hypertension
ESICM
European Society of Intensive Care Medicine
FAIR-HF
Ferinject® Assessment in patients with IRon deficiency and Chronic Heart Failure
FCM
Ferric carboxymaltose
FDA
Food and Drug Administration
GFR
Glomerular filtration rate
Hb
Haemoglobin
HD
Haemodialysis
HF
Heart failure
HR
Hazard ratio
ID
Iron deficiency
IDA
Iron deficiency anaemia
ISN
International Society of Nephrology
KDIGO
Kidney Disease Improving Global Outcomes
IV
Intravenous
LVEF
Left ventricular ejection fraction
MDRD
Modification of diet in renal disease
MSNA
Muscle sympathetic nerve activity
ND-CKC
Non-dialysis-dependent chronic kidney disease
NHANES
National Health and Nutrition Examination Survey
NKF-KDOQI
National Kidney Foundation–Kidney Disease Outcome Quality Initiative
NKF KEEP
National Kidney Foundation’s Kidney Early Evaluation Program
NT-proBNP
Natriuretic peptides
NYHA
New York Heart Association
QoL
Quality of life
RAAS
Renin-angiotensin-aldosterone system
RED-HF
Reduction of Events With Darbepoetin Alfa in Heart Failure
RD
Renal dysfunction
rHuEPO
Recombinant human erythropoietin
RI
Renal insufficiency
SD
Standard deviation
TREAT
Trial to Reduce Cardiovascular Events with Aranesp Therapy
UK
United Kingdom
US
United States
WCN
World Congress of Nephrology
WHO
World Health Organization
